Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AXTI vs MCHPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AXTI Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

AXTI Overall Winner 6-Pillar Tally: AXTI 3 – 3 MCHPP Matrix Metrics: AXTI 6 – 4 MCHPP

As of Nov 16, 2026, AXT Inc (AXTI) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). AXTI carries a Unified Composite Score of 54.2/100 (HOLD) at $38.16 (16.4x Forward P/E, 19.6% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).

  • Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. AXTI 54.2/100 HOLD), AXTI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (19.6% vs. 21.6% operating margin) and revenue trajectory (+162.6% vs. +42.2% YoY).
  • Technical & Structure Timing Caution: AXTI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.4); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AXTI vs MCHPP
AXTI NASDAQ Head-to-Head Winner
AXT Inc
Semiconductors & Related Devices
$38.16
-8.78% 1D
Market Cap $2.9B
TTM Revenue $171M
Forward P/E 16.4x
Beta / 30D Vol 4.37β · 158% Vol
Unified Composite Score
54.2 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 70.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.6%), weak momentum, RSI 37
RSI-14: 37.4 · SMA20: $49.49 · SMA50: $62.04
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
TTM Revenue $5.60B
Forward P/E N/M
Beta / 30D Vol 2.16β · 65% Vol
Unified Composite Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 32
RSI-14: 32.3 · SMA20: $61.25 · SMA50: $63.22

6-Pillar Scorecard Institutional Category Breakdown (AXTI 3 – 3 MCHPP)

Columns: Metric · AXTI · MCHPP
1. Valuation Multiples AXTI
Forward P/E 16.4x N/M
Trailing P/E 88.9x N/M
PEG Ratio 12.09x N/M
EV / Revenue 16.7x N/M
2. Growth & Scale AXTI
Revenue Growth (YoY) +162.6% +42.2%
Earnings Growth (YoY) -57.1% N/A
TTM Revenue (USD) $171M $5.60B
Market Cap $2.9B N/A
3. Profitability & Quality MCHPP
Gross Margin 44.0% 62.7%
Operating Margin 19.6% 21.6%
Net Profit Margin 18.5% 15.0%
Return on Equity (ROE) 6.1% 12.6%
4. Balance Sheet & Cash Flow MCHPP
Cash Generation (TTM) $43M EBITDA $1.87B EBITDA
Cash Flow Margin 25.3% EBITDA Mgn 33.3% EBITDA Mgn
Net Cash / Leverage $14.25 Book/Sh · 6.1% ROE $12.20 Book/Sh · 12.6% ROE
Dividend Yield None (0.00%) 6.84%
5. Options & Positioning AXTI
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 111.6% (13th %ile) N/A (N/A)
Put/Call OI Skew 1.42x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat MCHPP
OpEx & R&D Intensity 24.4% of Rev ($42M) 41.1% of Rev ($2.30B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Concentrated Oligopoly Moat Scale & Operating Efficiency Moat
Supply-Chain Role Semiconductor Equipment & Materials Operator Semiconductors Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AXTI (6) vs MCHPP (4)
Institutional Metric AXTI MCHPP Criterion Row Edge
Market Capitalization
Scale
$2.9B N/A Larger Scale AXTI
Trailing P/E Ratio
Valuation
88.9x N/M Lower Multiple AXTI
Forward P/E Ratio
Valuation
16.4x N/M Lower Multiple AXTI
Revenue Growth (YoY)
Growth
+162.6% +42.2% Higher Growth AXTI
Operating Margin (TTM)
Profitability
19.6% 21.6% Higher Margin MCHPP
Net Profit Margin
Profitability
18.5% 15.0% Higher Margin AXTI
Return on Equity (ROE)
Capital Efficiency
6.1% 12.6% Higher ROE MCHPP
52-Week Range Position
Momentum
22% ($8–$143) 14% ($47–$88) Stronger Trend AXTI
Beta / 30D Volatility
Risk Regime
4.37β · 158% Vol 2.16β · 65% Vol Lower Realized Risk MCHPP
Unified Institutional Score
Composite Signal
54.2 / 100 (HOLD) 57.1 / 100 (HOLD) Higher Composite MCHPP
Trailing 12M Revenue (USD)
Operating Scale
$171M $5.60B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.0% 62.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
12.09x PEG · 16.7x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$43M EBITDA ($14.25 Book/Sh · 6.1% ROE) $1.87B EBITDA ($12.20 Book/Sh · 12.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MCHPP +8.44 pp
AXTI: -25.85% · MCHPP: -17.41%
3M Horizon MCHPP +32.2 pp
AXTI: -53.63% · MCHPP: -21.43%
6M Horizon MCHPP +30.61 pp
AXTI: -63.95% · MCHPP: -33.34%
1Y Horizon AXTI +264.77 pp
AXTI: +265.57% · MCHPP: +0.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXTI vs MCHPP. Trailing 12-month operating profitability (AXTI 19.6% vs MCHPP 21.6%) and valuation multiples (AXTI 16.4x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AXTI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$171M
Gross Margin44.0%
Op. Margin19.6%
ROE / Fwd P/E6.1% · 16.4x
MCHPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.60B
Gross Margin62.7%
Op. Margin21.6%
ROE / Fwd P/E12.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AXTI BREAKDOWN
122d in phase · OBV NEUTRAL
Current IV 111.6%
IV Percentile 13th %ile
Put/Call OI Skew 1.42x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact AXTI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MCHPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MCHPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AXTI Moat Profile Concentrated Oligopoly Moat
Semiconductor Equipment & Materials Operator
Competes within the Semiconductor Equipment & Materials value chain with $2.9B market capitalization and 19.6% operating margin.
OpEx & R&D Reinvestment 24.4% of Rev ($42M)
90D Engineering Disclosures 0 Published · InP Lasers
Mapped Supply-Chain Ecosystem (15 partners):
Linde plc Air Liquide DuPont de Nemours Entegris
MCHPP Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with N/A market capitalization and 21.6% operating margin.
OpEx & R&D Reinvestment 41.1% of Rev ($2.30B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (19 partners):
Taiwan Semiconductor Manufacturing Company United Microelectronics Corporation Amkor Technology ASE Technology Holding

Investor FAQ AXTI vs MCHPP Key Questions & Quantitative Answers

As of Nov 16, 2026, AXT Inc (AXTI) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). AXTI carries a Unified Composite Score of 54.2/100 (HOLD) at $38.16 (16.4x Forward P/E, 19.6% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. AXTI 54.2/100 HOLD), AXTI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (19.6% vs. 21.6% operating margin) and revenue trajectory (+162.6% vs. +42.2% YoY). Technical & Structure Timing Caution: AXTI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.4); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AXTI leads the Growth & Scale pillar: AXTI posts +162.6% YoY revenue growth and -57.1% YoY earnings growth on $171M TTM revenue (44.0% gross margin, 19.6% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, AXTI generates $171M in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, AXTI deploys 24.4% of Rev ($42M) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.

AXTI screens cheaper on headline valuation multiples. AXTI trades at 16.4x Forward P/E, 88.9x Trailing P/E, 12.09x PEG, and 16.7x EV/Revenue (25.3% EBITDA margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AXTI (6.1% ROE) versus MCHPP (12.6% ROE) capital efficiency.

In options market volatility and institutional positioning, AXTI carries 111.6% implied volatility (13th %ile, Compressed (<25th %ile)), a 1.42x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.37β · 158% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.